• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Rare

Recent news which mentions Rare

< Previous 1 2 3 4 5 Next >
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Tickers ABBV ACAD ACER APYX
Tags ENTX ACER ELYM
From Benzinga
Ultragenyx Sells One-Third Of Future North American Crysvita Royalties For $500M
July 14, 2022
Tickers RARE
Tags Health Care News Briefs
From Benzinga
What 6 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical
July 01, 2022
Tickers RARE
Tags Analyst Ratings BZI/AAR RARE
From Benzinga
Netflix To $210? Here's The Biggest Price Target Changes For Friday
July 01, 2022
Tickers GS MU NFLX RARE
Tags NFLX Pre/Market Outlook RNLX
From Benzinga
Expert Ratings for Ultragenyx Pharmaceutical
May 24, 2022
Tickers RARE
Tags RARE Market News Benzinga
From Benzinga
Regeneron's Evkeeza Reduces Bad Cholesterol By 48% In Children Aged 5-11 Years
May 23, 2022
Tickers RARE REGN
Tags Briefs RARE News
From Benzinga
The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate
May 19, 2022
Tickers ADMP ENTA EVO IBB
Tags KDNY Benzinga MRSN
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
May 17, 2022
Tickers ABEO AGTC AKTX AMPE
Tags COVID/19 Vaccine OKYO Biotech
From Benzinga
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
May 16, 2022
Tickers ATNX AVRO AXDX BHVN
Tags MDWD SYRS RMED
From Benzinga
Citigroup Maintains Buy Rating for Ultragenyx Pharmaceutical: Here's What You Need To Know
May 10, 2022
Tickers RARE
Tags BZI/AAR/UPDATE Analyst Ratings RARE
From Benzinga
What 4 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical
May 06, 2022
Tickers RARE
Tags Benzinga Market News RARE
From Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Tickers ABUS AGIO ALDX ARGX
Tags NTLA AZN JAZZ
From Benzinga
Ultragenyx Pharmaceutical's Earnings Outlook
May 04, 2022
Tickers RARE
Tags Benzinga Market News Earnings
From Benzinga
These 20 highly rated stocks are expected to rise at least 70% over the next year
April 19, 2022
Tickers AGR AVLR AZEK CDK
Tags ZIMV MKSI XPO
From MarketWatch
Michael Farmer Announces First-Ever Auction at Christie's of His Meteorites from the Collection of Michael Farmer March 23, 2022 Through April 6, 2022
March 31, 2022
Tickers MOON RARE
Tags Mars Science Entertainment
From PRLog
What 4 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical
March 16, 2022
Tickers RARE
Tags Analyst Ratings BZI/AAR RARE
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022
March 16, 2022
Tickers ACAD BEKE CEG CPTN
Tags Downgrades NVO MU
From Benzinga
Where Ultragenyx Pharmaceutical Stands With Analysts
March 16, 2022
Tickers RARE
Tags Market News Benzinga RARE
From Benzinga
Ultragenyx Pharmaceutical: Q4 Earnings Insights
February 10, 2022
Tickers RARE
Tags RARE BZI/Recaps Benzinga
From Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Tickers AGLE ALNY ALVR ARMP
Tags VCEL AGLE LLY
From Benzinga
Earnings Scheduled For February 10, 2022
February 10, 2022
Tickers ACB AFRM AHH ALNY
Tags MTD Y FE
From Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Tickers ABBV ACLX ALNY AMGN
Tags IBB Trading Ideas ACLX
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 19, 2022
Tickers OWLT OZON PACB PALI
Tags VBLT PAYO TBLA
From Benzinga
These 60 stocks, including DraftKings, Zillow and Virgin Galactic, are down at least 50% from their 2021 highs
November 29, 2021
Tickers ADPT AGL AI AMED
Tags GME AI OSH
From MarketWatch
Ultragenyx Pharmaceutical inc (RARE) Q3 2021 Earnings Call Transcript
November 03, 2021
Tickers RARE
Tags Market News RARE
From Motley Fool
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
Tickers AADI AMGN AVNS CNTX
Tags VRTX Benzinga Guidance
From Benzinga
Earnings Scheduled For November 2, 2021
November 02, 2021
Tickers LDOS LEA LGIH LILA
Tags RARE TCS SRG
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Tickers ADPT AERI AGIO ALGS
Tags EXAS Biotech News
From Benzinga
What 4 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical
September 30, 2021
Tickers RARE
Tags RARE Benzinga Market News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2021
September 30, 2021
Tickers AANNF ABCB ABG ACCD
Tags Initiation PEG BZI/Ratings
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap